Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Sickle Cell Disease Association of America
7240 Parkway Drive, Suite 180Hanover, Maryland, United States
Email Phone Web
The vision for a national coordinated approach to addressing issues related to sickle cell disease was unveiled in 1971 when representatives of 15 community sickle cell organizations met at “Wingspread,” a Racine, Wisconsin conference center, as guest of the Johnson Foundation. Out of that meeting, the National Association for Sickle Cell Disease was created. The name was changed to Sickle Cell Disease Association of America, Inc. in 1994.
Our mission: “To advocate for and enhance our membership’s ability to improve the quality of health, life and services for individuals, families and communities affected by sickle cell disease and related conditions, while promoting the search for a cure for all people in the world with sickle cell disease. The Strategies defined at the “Wingspread” meeting laid the foundation for today’s Association.
-Provide leadership on a national level to create awareness of the negative impact of sickle cell disease on the health, economic, social and educational well-being of the individual and his or her family.
-Prepare and distribute substantive educational materials.
+myBinderRelated Content
-
Sickle cell patients, families and doctors face a ‘fight for everything’Francesca Valentine is gearing up for a ...
-
Benign Hematologic Disorders in Children, an Issue of Pediatric Clinics of North America, Volume 65-3This issue will provide a current update...
-
Patrick T. McGann, MD, MSPatrick T. McGann, MD, is the Director o...
-
Comparative Cost Analysis of Therapy in Sickle Cell Anemia: Supportive Care Vs. Bone Marrow TransplantObjective: A comparative cost analysis o...
-
Sickle Cell Disease & Hospitalizationhttps://www.youtube.com/watch?v=G_P4Uc9w...
-
Researchers Develop Effective Treatment for Sickle Cell Anemiahttps://www.youtube.com/watch?v=7zceTJzH...
-
Orphan Drug Designation Granted for CSL Behring’s Investigational Plasma-Derived Hemopexin Therapy for Sickle ...Global biotherapeutics leader CSL Behrin...
